Why the study?
Does bezafibrate improve post-prandial chylomicron and remnant clearance in male patients with hypertriglyceridaemic NIDDM?
Does bezafibrate improve post-prandial chylomicron and remnant clearance in male patients with hypertriglyceridaemic NIDDM?
Bezafibrate improves post-prandial lipolysis and chylomicron remnant removal in NIDDM patients, though remnant removal may become saturated in severe hypertriglyceridemia.
No takes yet. Share an insight, caveat, or question.
Bezafibrate may improve postprandial clearance in mild hypertriglyceridemic NIDDM; leaves open saturation effects and outcomes in severe cases.
Attia et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: